索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张雪莲,李岩松.光学相干断层成像在冠状动脉粥样硬化性心脏病中的应用进展[J].国际心血管病杂志,2020,06:355.
点击复制

光学相干断层成像在冠状动脉粥样硬化性心脏病中的应用进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2020年06期
页码:
355
栏目:
综述
出版日期:
2020-12-15

文章信息/Info

Title:
-
作者:
张雪莲; 李岩松
201600 上海市松江区中心医院心内科
Author(s):
-
关键词:
光学相干断层成像;  冠状动脉粥样硬化性心脏病;  介入治疗
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2020.06.010
文献标识码:
A
摘要:
腔内影像技术的出现是冠状动脉成像技术史上的重要进步,光学相干断层成像(OCT)技术具有高分辨率的特点,可以对腔内结构清楚成像。该文介绍OCT在冠状动脉粥样硬化性心脏病斑块性质识别、介入手术指导及支架优化植入、术后随访和药物效果评估等方面的作用。
Abstract:
-

参考文献/References

[1] Mintz GS. Clinical utility of intravascular imaging and physiology in coronary artery disease[J]. J Am Coll Cardiol, 2014, 64(2):207-222.
[2] Ali ZA, Karimi Galougahi K, Maehara A, et al. Intracoronary optical coherence tomography 2018: current status and future directions[J]. JACC Cardiovasc Interv, 2017, 10(24):2473-2487.
[3] Narula J, Nakano M, Virmani R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques[J]. J Am Coll Cardiol, 2013, 61(10):1041-1051.
[4] Usui E, Yonetsu T, Kanaji Y, et al. Optical coherence tomography-defined plaque vulnerability in relation to functional stenosis severity and microvascular dysfunction[J]. JACC Cardiovasc Interv, 2018, 11(20):2058-2068.
[5] Bourantas CV, Jaffer FA, Gijsen FJ, et al. Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology[J]. Eur Heart J, 2017, 38(6):400-412.
[6] Wijns W, Shite J, Jones MR, et al. Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN Ⅰ study[J]. Eur Heart J, 2015, 36(47):3346-3355.
[7] Amemiya K, Yamamoto MH, Maehara A, et al. Effect of cutting balloon after rotational atherectomy in severely calcified coronary artery lesions as assessed by optical coherence tomography[J]. Catheter Cardiovasc Interv, 2019, 94(7):936-944.
[8] Maehara A, Ben-Yehuda O, Ali Z, et al. Comparison of stent expansion guided by optical coherence tomography versus intravascular ultrasound: the ILUMIEN Ⅱ study(observational study of optical coherence tomography [OCT] in patients undergoing fractional flow reserve [FFR] and percutaneous coronary intervention)[J]. J Am Coll Cardiol Intv, 2015, 8:1704-1714.
[9] Ali ZA, Maehara A, Genereux P, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation(ILUMIEN Ⅲ: OPTIMIZE PCI): a randomised controlled trial[J]. Lancet, 2016, 388(160):2618-2628.
[10] Abdel-Karim AR, Uretsky BF. The importance of malapposition in angiographically optimized stenting in contemporaneous interventions[J]. Expert Rev Cardiovasc Ther, 2018, 16(8):599-605.
[11] Koyama K, Fujino A, Maehara A, et al. A prospective, single-center, randomized study to assess whether automated coregistration of optical coherence tomography with angiography can reduce geographic miss[J]. Catheter Cardiovasc Interv, 2019, 93(3):411-418.
[12] Sheth TN, Kajander OA, Lavi S, et al. Optical coherence tomography-guided percutaneous coronary intervention in ST-segment-elevation myocardial infarction: a prospective propensity-matched cohort of the thrombectomy versus percutaneous coronary intervention alone trial[J]. Circ Cardiovasc Interv, 2016, 9(4):e003414.
[13] Hougaard M, Hansen HS, Thayssen P, et al. Uncovered culprit plaque ruptures in patients with ST-segment elevation myocardial infarction assessed by optical coherence tomography and intravascular ultrasound with iMap[J]. JACC Cardiovasc Imaging, 2018, 11(6):859-867.
[14] Hara T, Gj U, Mccarthy JR, et al. Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo[J]. Eur Heart J, 2017, 38(6):447-455.
[15] Burzotta F, Trani C. Intracoronary imaging[J]. Circ Cardiovasc Interv, 2018, 11(11):e007461.
[16] Souteyrand G, Amabile N, Mangin L, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry[J]. Eur Heart J, 2016, 37(15):1208-1216.
[17] Taniwaki M, Radu MD, Zaugg S, et al. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography[J]. Circulation, 2016, 133(7):650-660.
[18] Sotomi Y, Suwannasom P, Serruys PW, et al. Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging[J]. EuroIntervention, 2017, 12(14):1747-1756.
[19] Patel A, Nazif T, Stone GW, et al. Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis[J]. Catheter Cardiovasc Interv, 2017, 89(5):876-879.
[20] Stone GW, Granada JF. Very late thrombosis after bioresorbable scaffolds: cause for concern?[J]. J Am Coll Cardiol, 2015, 66(17):1915-1917.
[21] Lee Y, Park HC, Shin J. Clinical efficacy of aspirin with identification of intimal morphology by optical coherence tomography in preventing event recurrence in patients with vasospasm-induced acute coronary syndrome[J]. Int J Cardiovasc Imaging, 2018, 34(11):1697-1706.
[22] Nishiguchi T, Kubo T, Tanimoto T, et al. Effect of early pitavastatin therapy on coronary fibrous-cap thickness assessed by optical coherence tomography in patients with acute coronary syndrome: the Escort study[J]. JACC Cardiovasc Imaging, 2018, 11(6):829-838.
[23] Valgimigli M, Frigoli E, Leonardi S, et al. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome(MATRIX): final 1-year results of a multicentre, randomised controlled trial[J]. Lancet, 2018, 392(1150):835-848.
[24] Gargiulo G, Carrara G, Frigoli E, et al. Bivalirudin or heparin in patients undergoing invasive management of acute coronary syndromes[J]. J Am Coll Cardiol, 2018, 71(11):1231-1242.
[25] Shah R, Matin K, Rogers KC, et al. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: a comprehensive pairwise and network meta-analysis of randomized controlled trials[J]. Catheter Cardiovasc Interv, 2017, 90(2):196-204.
[26] Garcia-Garcia HM, Picchi A, Sardella G, et al. Comparison of intra-procedural vs. post-stenting prolonged bivalirudin infusion for residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing: the MATRIX(Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX)OCT study[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(12):1418-1428.
[27] Francaviglia B, Capranzano P, Gargiulo G, et al. Usefulness of 3D OCT to diagnose a noncircumferential open-cell stent fracture[J]. JACC Cardiovasc Imaging, 2016, 9(2):210-211.

备注/Memo

备注/Memo:
基金项目:松江区科技攻关项目(19sjkjgg139)通信作者:张雪莲,E-mail:229614925@qq.com
更新日期/Last Update: 2020-12-15